Literature DB >> 18322368

Etiology and pathophysiology of frontotemporal dementia, Parkinson disease and Alzheimer disease: lessons from genetic studies.

Christian Wider1, Zbigniew K Wszolek.   

Abstract

Genetic studies have led to major discoveries in the pathogenesis of various neurodegenerative diseases. Ubiquitin-positive familial frontotemporal dementia was recently found to be caused by mutations in the progranulin gene (PGRN), and the major constituent of the inclusions, TDP-43, was subsequently identified. The tau gene (MAPT) causes frontotemporal dementia with parkinsonism linked to chromosome 17. In Parkinson disease, LRRK2 mutations have emerged as a major cause of both familial and sporadic forms, adding to the previously known genes SNCA,PRKN,DJ1 and PINK1. Several genes have been implicated in Alzheimer disease, including the APP gene and the PSEN genes. Recently, variants in the sortilin-related receptor 1 gene, SORL1, were associated with Alzheimer disease. 2008 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2008        PMID: 18322368      PMCID: PMC2826449          DOI: 10.1159/000113680

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  22 in total

1.  A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan.

Authors:  Alessio Di Fonzo; Yah-Huei Wu-Chou; Chin-Song Lu; Marina van Doeselaar; Erik J Simons; Christan F Rohé; Hsiu-Chen Chang; Rou-Shayn Chen; Yi-Hsin Weng; Nicola Vanacore; Guido J Breedveld; Ben A Oostra; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2006-04-22       Impact factor: 2.660

2.  G2019S LRRK2 mutation in French and North African families with Parkinson's disease.

Authors:  Suzanne Lesage; Pablo Ibanez; Ebba Lohmann; Pierre Pollak; François Tison; Myriem Tazir; Anne-Louise Leutenegger; Joao Guimaraes; Anne-Marie Bonnet; Yves Agid; Alexandra Dürr; Alexis Brice
Journal:  Ann Neurol       Date:  2005-11       Impact factor: 10.422

3.  APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy.

Authors:  Anne Rovelet-Lecrux; Didier Hannequin; Gregory Raux; Nathalie Le Meur; Annie Laquerrière; Anne Vital; Cécile Dumanchin; Sébastien Feuillette; Alexis Brice; Martine Vercelletto; Frédéric Dubas; Thierry Frebourg; Dominique Campion
Journal:  Nat Genet       Date:  2005-12-20       Impact factor: 38.330

4.  Common variants in Parkinson's disease.

Authors:  Owen A Ross; Matthew J Farrer; Ruey-Meei Wu
Journal:  Mov Disord       Date:  2007-04-30       Impact factor: 10.338

Review 5.  Genetics of Parkinson disease: paradigm shifts and future prospects.

Authors:  Matthew James Farrer
Journal:  Nat Rev Genet       Date:  2006-04       Impact factor: 53.242

6.  Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations.

Authors:  Jennifer Kachergus; Ignacio F Mata; Mary Hulihan; Julie P Taylor; Sarah Lincoln; Jan Aasly; J Mark Gibson; Owen A Ross; Timothy Lynch; Joseph Wiley; Haydeh Payami; John Nutt; Demetrius M Maraganore; Krzysztof Czyzewski; Maria Styczynska; Zbigniew K Wszolek; Matthew J Farrer; Mathias Toft
Journal:  Am J Hum Genet       Date:  2005-02-22       Impact factor: 11.025

7.  Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity.

Authors:  Andrew B West; Darren J Moore; Saskia Biskup; Artem Bugayenko; Wanli W Smith; Christopher A Ross; Valina L Dawson; Ted M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-03       Impact factor: 11.205

8.  Evaluation of LRRK2 G2019S penetrance: relevance for genetic counseling in Parkinson disease.

Authors:  S Goldwurm; M Zini; L Mariani; S Tesei; R Miceli; F Sironi; M Clementi; V Bonifati; G Pezzoli
Journal:  Neurology       Date:  2007-01-10       Impact factor: 9.910

9.  Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease.

Authors:  Alessio Di Fonzo; Cristina Tassorelli; Michele De Mari; Hsin F Chien; Joaquim Ferreira; Christan F Rohé; Giulio Riboldazzi; Angelo Antonini; Gianni Albani; Alessandro Mauro; Roberto Marconi; Giovanni Abbruzzese; Leonardo Lopiano; Emiliana Fincati; Marco Guidi; Paolo Marini; Fabrizio Stocchi; Marco Onofrj; Vincenzo Toni; Michele Tinazzi; Giovanni Fabbrini; Paolo Lamberti; Nicola Vanacore; Giuseppe Meco; Petra Leitner; Ryan J Uitti; Zbigniew K Wszolek; Thomas Gasser; Erik J Simons; Guido J Breedveld; Stefano Goldwurm; Gianni Pezzoli; Cristina Sampaio; Egberto Barbosa; Emilia Martignoni; Ben A Oostra; Vincenzo Bonifati
Journal:  Eur J Hum Genet       Date:  2006-03       Impact factor: 4.246

Review 10.  Expanding insights of mitochondrial dysfunction in Parkinson's disease.

Authors:  Patrick M Abou-Sleiman; Miratul M K Muqit; Nicholas W Wood
Journal:  Nat Rev Neurosci       Date:  2006-03       Impact factor: 34.870

View more
  12 in total

1.  Comparative survey of the topographical distribution of signature molecular lesions in major neurodegenerative diseases.

Authors:  Steven E Arnold; Jon B Toledo; Dina H Appleby; Sharon X Xie; Li-San Wang; Young Baek; David A Wolk; Edward B Lee; Bruce L Miller; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Comp Neurol       Date:  2013-12-15       Impact factor: 3.215

Review 2.  Gait dynamics in Parkinson's disease: common and distinct behavior among stride length, gait variability, and fractal-like scaling.

Authors:  Jeffrey M Hausdorff
Journal:  Chaos       Date:  2009-06       Impact factor: 3.642

Review 3.  Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).

Authors:  Dennis W Dickson; Naomi Kouri; Melissa E Murray; Keith A Josephs
Journal:  J Mol Neurosci       Date:  2011-07-01       Impact factor: 3.444

Review 4.  Mitochondrial Quality Control Proteases in Neuronal Welfare.

Authors:  Roman M Levytskyy; Edward M Germany; Oleh Khalimonchuk
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-02       Impact factor: 4.147

Review 5.  Neuropathology of non-Alzheimer degenerative disorders.

Authors:  Dennis W Dickson
Journal:  Int J Clin Exp Pathol       Date:  2009-08-25

6.  Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis.

Authors:  Nicola J Rutherford; Yong-Jie Zhang; Matt Baker; Jennifer M Gass; Nicole A Finch; Ya-Fei Xu; Heather Stewart; Brendan J Kelley; Karen Kuntz; Richard J P Crook; Jemeen Sreedharan; Caroline Vance; Eric Sorenson; Carol Lippa; Eileen H Bigio; Daniel H Geschwind; David S Knopman; Hiroshi Mitsumoto; Ronald C Petersen; Neil R Cashman; Mike Hutton; Christopher E Shaw; Kevin B Boylan; Bradley Boeve; Neill R Graff-Radford; Zbigniew K Wszolek; Richard J Caselli; Dennis W Dickson; Ian R Mackenzie; Leonard Petrucelli; Rosa Rademakers
Journal:  PLoS Genet       Date:  2008-09-19       Impact factor: 5.917

7.  Feasibility study of a wearable system based on a wireless body area network for gait assessment in Parkinson's disease patients.

Authors:  Jorge Cancela; Matteo Pastorino; Maria T Arredondo; Konstantina S Nikita; Federico Villagra; Maria A Pastor
Journal:  Sensors (Basel)       Date:  2014-03-07       Impact factor: 3.576

8.  Wearability assessment of a wearable system for Parkinson's disease remote monitoring based on a body area network of sensors.

Authors:  Jorge Cancela; Matteo Pastorino; Alexandros T Tzallas; Markos G Tsipouras; Giorgios Rigas; Maria T Arredondo; Dimitrios I Fotiadis
Journal:  Sensors (Basel)       Date:  2014-09-16       Impact factor: 3.576

9.  TDP-43 Inhibits NF-κB Activity by Blocking p65 Nuclear Translocation.

Authors:  Jingyan Zhu; Max S Cynader; William Jia
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

Review 10.  The effects of transcranial direct current stimulation on gait in patients with Parkinson's disease: a systematic review.

Authors:  Fateme Pol; Mohammad Ali Salehinejad; Hamzeh Baharlouei; Michael A Nitsche
Journal:  Transl Neurodegener       Date:  2021-06-29       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.